Pear Bio Stock

Pear Bio utilizes organ-on-chip & computer vision to model the spread of cancer and assess drug impacts on its progression.

Sign up today and learn more about Pear Bio Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Pear Bio Stock

Pear Bio s a computational biology company developing a microtumor technology that recreates core parts of the human tumor-immune microenvironment for functional precision medicine testing and drug discovery. The Pear platform combines 3D cell culture, functional testing, computer vision and multi-omics analysis. Pear Bio has active clinical trials to predict patient response to therapy, and an internal drug discovery pipeline based on the functional and multi-omic analysis of patient tumor and blood samples and real-world patient data.

Funding History

December 2020$1.2M
November 2021$4.6M
May 2023$14.0M

Management

CEO

Duleek Ranatunga

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo